Therefore, given the lack of effective targeted therapies, the poor prognosis of TNBC patients, and the close relationship between BRCA1/2-MUT BC and TNBC, we also aimed to further identify closely related genes between these two subtypes, in order to reveal underlying molecular relations and promising therapeutic targets. This evidence concerns the gene BRCA1 and breast cancer.